MedTrace Logo

Safety and Efficacy of an Intrastromal Transform™ Corneal Allograft (TCA) for Presbyopia Correction

NCT03671135 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2024-02-23

No results posted yet for this study

Summary

The objective of this clinical study is to evaluate the safety and effectiveness of intrastromal implantation of the Allotex TransForm corneal allograft (TCA) for improving near vision in presbyopic subjects.

Conditions

Interventions

OTHER

TCA Intrastromal Inlay

Anterior surface of Bowmans Layer Corneal Optical Correction Inlay

Sponsors & Collaborators

  • Allotex, Inc.

    lead INDUSTRY

Principal Investigators

  • Vance Thompson, MD · Study Medical Monitor/Consultant

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-09
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Belgium
  • Ireland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03671135 on ClinicalTrials.gov